STADA Arzneimittel

    OverviewSuggest Edit

    STADA Arzneimittel Aktiengesellschaft engages in the development and marketing of active pharmaceutical ingredients for the health care and pharmaceutical markets worldwide. It operates through two segments, Generics and Branded Products. The Generics segment provides various generic active ingredients, including Tilidine naloxone for pain; Atorvastatin for elevated cholesterol levels; Pantoprazole for stomach ulcer/reflux; Diclofenac for pain/inflammation; and Enalapril for high blood pressure indications. The Branded Products segment offers APO-Go a Parkinson’s medicine; Aqualor for rhinitis/sore throat; Grippostad a cold medicine; Snup for rhinitis; and Vitaprost for prostate disease indications, as well as Ladival a sun protection product. The company is also involved in the wholesale activities in the pharmaceutical market. It serves patients and/or consumers, doctors, doctors’ cooperatives, pharmacies, pharmacy cooperatives, hospitals, wholesalers, and other service providers in the health care market, as well as public health insurance organizations or private insurances. The company was founded in 1895 and is headquartered in Bad Vilbel, Germany.
    HQBad Vilbel, DE

    Latest Updates

    Employees (est.) (Nov 2018)10,232(-7%)

    Key People/Management at STADA Arzneimittel

    Peter Goldschmidt

    Peter Goldschmidt

    Chairman of the Executive Board/CEO
    Mark Keatley

    Mark Keatley

    Chief Financial Officer/CFO
    Miguel Pagan Fernandez

    Miguel Pagan Fernandez

    Chief Technical Officer/CTO
    Show more

    STADA Arzneimittel Office Locations

    STADA Arzneimittel has an office in Bad Vilbel
    Bad Vilbel, DE (HQ)
    2 Stadastraße
    Show all (1)

    STADA Arzneimittel Online and Social Media Presence

    Embed Graph

    STADA Arzneimittel News and Updates

    Explore How Generic Medicine Market is growing with list of key players such as Teva, Novartis – Sandoz, Allergan, Mylan, Sun Pharmaceutical, Aspen, Hospira, Sanofi, Fresenius Kabi, Stada Arzneimittel, Aurobindo, Cipla, Krka Group

    These similarities help to demonstrate bioequivalence, which means that a generic medicine works in the same way and provides the same clinical benefit as its brand-name version. Posted via Industry Today. Follow us on Twitter @IndustryToday

    STADA Arzneimittel Frequently Asked Questions

    • When was STADA Arzneimittel founded?

      STADA Arzneimittel was founded in 1895.

    • Who are STADA Arzneimittel key executives?

      STADA Arzneimittel's key executives are Peter Goldschmidt, Mark Keatley and Miguel Pagan Fernandez.

    • How many employees does STADA Arzneimittel have?

      STADA Arzneimittel has 10,232 employees.

    • Who are STADA Arzneimittel competitors?

      Competitors of STADA Arzneimittel include Faes Farma, AbbVie and SciClone Pharmaceuticals.

    • Where is STADA Arzneimittel headquarters?

      STADA Arzneimittel headquarters is located at 2 Stadastraße, Bad Vilbel.

    • Where are STADA Arzneimittel offices?

      STADA Arzneimittel has an office in Bad Vilbel.

    • How many offices does STADA Arzneimittel have?

      STADA Arzneimittel has 1 office.